Thanks to the derogatory development during the COVID-19, telemedicine in France is better legally regulated and more accessible
DOI:
https://doi.org/10.1344/rbd2023.57.41721Abstract
Telemedicine has existed since the 1980s and puts a patient in contact with a doctor or health professional at a distance who exchanges digital data using computer tools. The Ordre des Médecins considers that new technologies facilitate access to care and specialised expertise, even if it goes against fundamental ethical principles. It is a substitute for the traditional medical act, and one must question its relevance and whether the conditions of implementation bring a benefit to the patient.During the Covid-19 epidemic, the conditions for telemedicine were relaxed and the health insurance system facilitated its reimbursement in a derogatory manner. Healthcare professionals, healthcare institutions and patients were able to appreciate the new possibilities offered by telemedicine and recognize its limitations. However, safety is not the main concern of patients, who make extensive use of IT tools to surf the Internet and consider remote medicine as an easily accessible exercise without knowing its limits. They do not distinguish between medically supervised clinical telemedicine and e-health services offered over the Internet, which are commercial wellness offerings. In this presentation, we will first describe the evolution of telemedicine, which has long been implemented in France in various forms, and then the spectacular development of teleconsultations during the COVID-19 epidemic, the beneficial consequences of which allow better accessibility and reimbursement by social security.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anne Marie Duguet
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The author retains the copyright and grants Revista de Bioética y Derecho the right of first publication of the article. All articles published in Revista de Bioética y Derecho are under Creative Commons licensing Recognition – Non Commercial – NoDerivedArtwork (by-nc-nd 4.0), which allows sharing the content with third parties, provided that they acknowledge its authorship, initial publication in this journal and the terms of the license. No commercial use of the original work or generation of derivative works is permitted.